ArticleCancer immunology research2024

Tumor-Associated Antigen Burden Correlates with Immune Checkpoint Blockade Benefit in Tumors with Low Levels of T-cell Exhaustion.

Yue Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.